Celldex Therapeutics, Inc (CLDX) Stock Price

CLDXStock

$41.22+80.63%52W

Market Cap$3.24B

P/E—

PEG Ratio—

Div yield—

Beta0.85

CLDX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)65.15%

Price vs S&P 500 (4W)10.97%

VGM Score29.55

Book Value / Share (Quarterly)$9.10

P/TBV (Annual)3.61x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-13.17%

Cash Flow / Share (Quarterly)$-3.08

Price vs S&P 500 (YTD)37.42%

Gross Margin (TTM)17.65%

Net Profit Margin (TTM)-147787.97%

EPS (TTM)$-4.36

10-Day Avg Trading Volume0.92M

EPS Excl Extra (TTM)$-4.36

Revenue Growth (5Y)-26.94%

EPS (Annual)$-3.90

ROI (Annual)-49.08%

Gross Margin (Annual)100.00%

Net Profit Margin (5Y Avg)-5465.53%

Cash / Share (Quarterly)$9.14

Revenue Growth QoQ (YoY)-96.99%

ROA (Last FY)-44.38%

Revenue Growth TTM (YoY)-97.27%

EBITD / Share (TTM)$-4.65

ROE (5Y Avg)-30.88%

Operating Margin (TTM)-159627.22%

Cash Flow / Share (Annual)$-3.21

P/B Ratio4.74x

P/B Ratio (Quarterly)4.09x

Net Income / Employee (Annual)$-1,306,900

EV / Revenue (TTM)21143.69x

Net Interest Coverage (TTM)-740.36x

ROA (TTM)-47.61%

EPS Incl Extra (Annual)$-3.90

Current Ratio (Annual)10.49x

Quick Ratio (Quarterly)11.71x

3-Month Avg Trading Volume0.96M

52-Week Price Return80.63%

Revenue / Employee (TTM)$800

Tangible BV / Share (Quarterly)$8.76

P/S Ratio (Annual)2192.98x

Asset Turnover (Annual)0.00x

52-Week High$45.14

Operating Margin (5Y Avg)-6007.73%

EPS Excl Extra (Annual)$-3.90

CapEx CAGR (5Y)11.86%

Tangible BV CAGR (5Y)22.86%

26-Week Price Return76.39%

Quick Ratio (Annual)10.21x

13-Week Price Return32.67%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)11.82x

Enterprise Value$3.34B

Revenue / Share Growth (5Y)-37.80%

Asset Turnover (TTM)0.00x

Book Value / Share Growth (5Y)8.43%

Revenue / Employee (Annual)$7,800

Inventory Turnover (Annual)0.80x

Pretax Margin (Annual)-16748.03%

Cash / Share (Annual)$7.79

3-Month Return Std Dev42.14%

Gross Margin (5Y Avg)44.59%

Net Income / Employee (TTM)$-1,517,900

ROE (Last FY)-49.08%

Net Interest Coverage (Annual)-55.51x

EPS Basic Excl Extra (Annual)$-3.90

P/FCF (TTM)108.80x

Receivables Turnover (TTM)0.99x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-4.36

Receivables Turnover (Annual)1.14x

ROI (TTM)-52.35%

P/S Ratio (TTM)21444.03x

Pretax Margin (5Y Avg)-5466.52%

Revenue / Share (Annual)$0.02

Tangible BV / Share (Annual)$7.51

Price vs S&P 500 (52W)62.32%

Year-to-Date Return49.37%

5-Day Price Return-2.92%

EPS Normalized (Annual)$-3.90

ROA (5Y Avg)-28.48%

Net Profit Margin (Annual)-16748.03%

Month-to-Date Return6.59%

Cash Flow / Share (TTM)$-2.58

EBITD / Share (Annual)$-4.28

Operating Margin (Annual)-18599.81%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-30.88%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-4.36

P/TBV (Quarterly)4.25x

P/B Ratio (Annual)3.42x

Inventory Turnover (TTM)0.80x

Pretax Margin (TTM)-147787.97%

Book Value / Share (Annual)$7.92

Price vs S&P 500 (13W)29.87%

Beta0.85x

P/FCF (Annual)199.54x

Revenue / Share (TTM)$0.00

ROE (TTM)-52.35%

52-Week Low$21.34

vGradeF

gGradeF

mGradeB

vgmGradeD

CLDX Earnings Surprise History

Q2 25-0.85est. -0.84

Q3 25-1.01est. -0.89

Q4 25-1.22est. -1.00

Q1 26-1.18est. -1.13

Q2 26-0.94est. -1.06

CLDX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.23

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	Price
CLDXCelldex Therapeutics, Inc	F	F	B	$41.22
IDXXIdexx Laboratories Inc	D	B	C	$550.01
LNTHLantheus Holdings, Inc	C	B	B	$100.87
NEOGNeogen Corp	C	C	B	$11.64
NTLAIntellia Therapeutics, Inc	D	D	C	$13.51
QDELQuidelOrtho Corporation Common Stock	C	C	C	$15.05
ACHVAchieve Life Sciences, Inc.	F	F	A	$8.17
TKNOAlpha Teknova, Inc. Common Stock	D	C	A	$7.46
NNNNAnbio Biotechnology Class A Ordinary Shares	F	B	F	$7.83
MYGNMyriad Genetics Inc	B	C	D	$3.19
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	$4.44
ICCCImmucell Corp	C	B	B	$9.84
QCLSQ/C Technologies, Inc. Common Stock	C	—	F	$2.44
TRIBTrinity Biotech plc	B	D	F	$9.71
CDIOCardio Diagnostics Holdings Inc. Common stock	—	C	B	$1.91
BMRABIOMERICA INC	B	D	D	$1.77
VNRXVolitionRx Limited	B	A	F	$0.38
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	D	$2.91
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	C	$0.01

About Celldex Therapeutics, Inc

Celldex Therapeutics develops monoclonal and bispecific antibodies to treat mast cell-mediated inflammatory, allergic, and autoimmune diseases. The company combines research in mast cell biology with manufacturing and commercialization capabilities to advance its therapeutic pipeline.